Clinic of Aesthetic Plastic Surgery, Toblerstrasse 51, Zürich, Switzerland.
Aesthetic Plast Surg. 2010 Aug;34(4):502-7. doi: 10.1007/s00266-010-9488-8. Epub 2010 Mar 24.
Acute hematoma remains one of the most frequently encountered complications after face-lift surgery. Several risk factors inherent to the patient and omission of certain intraoperative regimens are considered to cause hematoma. Significant risk factors include high blood pressure and male gender. Possible intraoperative regimens for the prevention of hematoma include tumescence infiltration without adrenaline, clotting of raw surfaces with fibrin glue, usage of drains, and application of compression bandages. However, little attention has been paid to postoperative measures. To examine whether different regimens in the postoperative phase can influence the incidence of hematoma, all face-lift patients who underwent surgery by a single surgeon in two different clinics (n = 376) with two different postoperative regimens were evaluated over the course of 3 years. In group 1 (n = 308), all postoperative medication was administered on request including medication for pain control, blood pressure stabilization, and prevention of nausea and vomiting as well as postoperative restlessness and agitation. In group 2 (n = 68), this medication was administered prophylactically at the end of the operation before extubation. The hematoma rate was 7% in group 1 and 0% in group 2. This study showed that the prophylactic use of medications (e.g., analgesics, antihypertonics, antiemetics, and sedatives) during the postoperative phase is superior to making drugs available to patients on request and can decrease the occurrence of acute hematoma in face-lift patients.
急性血肿仍然是面部提升手术后最常见的并发症之一。一些与患者相关的固有风险因素和术中方案的遗漏被认为会导致血肿。显著的风险因素包括高血压和男性性别。预防血肿的可能术中方案包括不含肾上腺素的肿胀浸润、纤维蛋白胶凝固创面、使用引流管和应用压缩绷带。然而,术后措施很少受到关注。为了研究术后不同方案是否会影响血肿的发生率,对在 3 年内由同一位外科医生在两家不同诊所进行手术的所有面部提升患者(n=376)进行了评估,这些患者采用了两种不同的术后方案。在第 1 组(n=308)中,所有术后药物均按需使用,包括用于止痛、稳定血压、预防恶心和呕吐以及术后不安和激动的药物。在第 2 组(n=68)中,这些药物在手术结束时拔管前预防性使用。第 1 组的血肿发生率为 7%,第 2 组为 0%。本研究表明,在术后阶段预防性使用药物(如镇痛药、抗高血压药、止吐药和镇静剂)优于按需向患者提供药物,并可降低面部提升患者急性血肿的发生。